Larissa Lezina

1.3k citations
20 papers · 1.0k indexed · h-index 14
Topics
Epigenetics and DNA Methylation (5 papers)Cancer-related Molecular Pathways (4 papers)RNA modifications and cancer (3 papers)

In The Last Decade

Larissa Lezina

20 papers receiving 1.0k citations

Peers

Larissa Lezina
Comparison fields: 5 of 95
  • Molecular Biology 679
  • Oncology 222
  • Physiology 149
  • Immunology 127
  • Cancer Research 124
Replace Takashi Furusawa with:
Takashi Furusawa United States
Shiu-Huey Chou Taiwan
Jia You China
Pooja Agarwal United States
Zhengyun Zou China
Chongkui Sun China
Hirokazu Ohata Japan
Md Zahidul Islam Pranjol United Kingdom
Zhenglan Huang China
William Putzbach United States
Larissa Lezina relative to Takashi Furusawa United States Takashi Furusawa's profile →
Citations per field
00.5×1.5×2.2×
Takashi Furusawa · 1×
Citations per year

Countries citing papers authored by Larissa Lezina

Since Specialization
Citations

This map shows the geographic impact of Larissa Lezina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larissa Lezina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larissa Lezina more than expected).

Fields of papers citing papers by Larissa Lezina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larissa Lezina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larissa Lezina. The network helps show where Larissa Lezina may publish in the future.

Co-authorship network of co-authors of Larissa Lezina

This figure shows the co-authorship network connecting the top 25 collaborators of Larissa Lezina. A scholar is included among the top collaborators of Larissa Lezina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larissa Lezina. Larissa Lezina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 9
4 12
5 26
6 139
7 14
8 12
9 42
10 47
11 50
12 47
13 209
14 67
15 37
16 155
17 10
18 104
19 16
20 43

About Larissa Lezina

Larissa Lezina is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Aging (26 citations), Molecular Biology (679 citations) and Analytical Chemistry (94 citations). Larissa Lezina has collaborated with scholars based in United Kingdom, Russia and United States. Frequent co-authors include Nickolai A. Barlev, Alexey V. Antonov, Paul M. Lieberman, Salvador Macip, Nick A. Barlev, Gerry Melino, Susan Giblett, Jinli Luo, C. T. Foster and Timothy W. Gant. Their work appears in journals such as Journal of Biological Chemistry, Nano Letters and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026